These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31444077)

  • 1. [Project management of the implementation of intracranial stereotactic body radiotherapy at the "Centre finistérien de radiothérapie et d'oncologie"].
    Ponsard N; Lasserre L; Caradec A; Couppa É
    Cancer Radiother; 2019 Oct; 23(6-7):523-525. PubMed ID: 31444077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [French Health Authority certification visit in a radiotherapy department].
    Ponsard N; Heddadi L; Pradier O
    Cancer Radiother; 2020 Oct; 24(6-7):722-725. PubMed ID: 32792296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frameless set-up with ExacTrac
    Ohnleiter T; Mahé MA; Biau J; Wdowczyk D; Clavier JB; Antoni D; Noël G
    Cancer Radiother; 2016 Dec; 20(8):768-775. PubMed ID: 27449858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stereotactic radiosurgery and radiotherapy for brain metastases].
    Tanguy R; Métellus P; Mornex F; Mazeron JJ
    Bull Cancer; 2013 Jan; 100(1):75-81. PubMed ID: 23376580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Organization and risk management in stereotaxic body radiotherapy at the treatment station].
    Bouvet C; Bertin K; Lafond C; Williaume D; de Crevoisier R; Leroy E
    Cancer Radiother; 2018 Oct; 22(6-7):532-536. PubMed ID: 30181030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spinal stereotactic body radiotherapy: French assessment in 2016].
    Pougnet I; Jaegle E; Garcia R; Tessier F; Faivre JC; Louvel G; Gross E; Gonzague L; Benchalal M; Ducteil A; Supiot S; Autret D; Clavier JB; Mirabel X; Bellière A; Wdowczyk D; Heymann S; Barillot I; de La Lande B; Passerat V; Sunyach MP; Lipinski F; Thibouw D; Guichard F; Chauvet B; Thariat J; Arnaud A
    Cancer Radiother; 2017 Jun; 21(4):276-285. PubMed ID: 28499659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nationwide implementation of stereotactic radiotherapy: the challenges of initial training and continuing professional education].
    Bibault JE; Denis F; Marchesi V; Lisbona A; Noël G; Mahé MA
    Cancer Radiother; 2014 Oct; 18(5-6):387-90. PubMed ID: 25179253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionated stereotactic radiotherapy.
    Shrieve DC; Kooy HM; Tarbell NJ; Loeffler JS
    Important Adv Oncol; 1996; ():205-24. PubMed ID: 8791137
    [No Abstract]   [Full Text] [Related]  

  • 9. [From quality management to dynamic management through quality: Deployment within a radiotherapy group].
    Guerrier B; Halm É; Craman M; Dujols JP; Norkowski JL; Meynard K
    Cancer Radiother; 2017 Oct; 21(6-7):655-661. PubMed ID: 28890090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensity-modulated radiation therapy and stereotactic body radiation therapy for head and neck tumors: evidence-based medicine].
    Lapierre A; Martin F; Lapeyre M
    Cancer Radiother; 2014 Oct; 18(5-6):468-72. PubMed ID: 25155467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Irradiation in stereotactic conditions: prerequisites].
    Maingon P; Lisbona A
    Cancer Radiother; 2014 Oct; 18(5-6):383-6. PubMed ID: 25179251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Equipment and positioning technologies in stereotactic body radiation therapy].
    Marchesi V; Dedieu V; Lacornerie T; Buchheit I
    Cancer Radiother; 2014; 18(4):253-7. PubMed ID: 24837350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?].
    Riou O; Valdenaire S; Debuire P; Fenoglietto P; Debrigode C; Mazard T; Assenat É; Aillères N; Azria D
    Cancer Radiother; 2019 Oct; 23(6-7):636-650. PubMed ID: 31444078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stereotactic body radiation therapy: uncertainties and margins].
    Lacornerie T; Marchesi V; Reynaert N
    Cancer Radiother; 2014; 18(4):258-63. PubMed ID: 25023588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AFQSR: A concrete and active implication in the service of the radiotherapy in 2018].
    Ponsard N
    Cancer Radiother; 2018 Oct; 22(6-7):537-539. PubMed ID: 30150088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in intracranial stereotactic radiotherapy for metastases.
    Pinkham MB; Whitfield GA; Brada M
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):316-23. PubMed ID: 25662094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of CNS disease in ALK-positive non-small cell lung cancer: Is whole brain radiotherapy still needed?
    Wrona A
    Cancer Radiother; 2019 Sep; 23(5):432-438. PubMed ID: 31331844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stereotactic convergence irradiation with linear accelerator. Imaging,technique and clinical indications].
    Grosu AL; Stärk S; Feldmann HJ; Kneschaurek P; Leonardi M; Lumenta C; Molls M
    Rontgenpraxis; 1998 Mar; 51(1-2):9-15. PubMed ID: 9594633
    [No Abstract]   [Full Text] [Related]  

  • 19. [Postoperative brain radiotherapy: role of stereotactic radiotherapy].
    Thillays F; Doré M; Martin SA
    Cancer Radiother; 2013 Oct; 17(5-6):407-12. PubMed ID: 24011794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery and stereotactic radiotherapy in the treatment of skull base meningiomas.
    McGregor JM; Sarkar A
    Otolaryngol Clin North Am; 2009 Aug; 42(4):677-88. PubMed ID: 19751872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.